SURE-HF: Urinary Sodium-Guided Diuretic Therapy in Heart Failure

A trial with no phase registered on ClinicalTrials.gov. The registry status is not yet recruiting. It plans to enroll 260 participants.

Also called NCT07631780

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose treatment
Phase
Not applicable
Enrolled
  • 260 participants (planned count) (from the registry)
Sponsor
Registry
  • NCT NCT07631780
Planned start
(anticipated) (from the registry)
Primary completion
(anticipated) (from the registry)
Completion
(anticipated) (from the registry)
Countries
Kazakhstan (from the registry)
Registry status
  • Not yet recruiting (from the registry)

Technical summary

Registry record NCT07631780. Randomized; no masking; primary purpose treatment. Start 2026-06 (anticipated); primary completion 2027-12 (anticipated). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
SURE-HF: Urinary Sodium-Guided Diuretic Therapy in Heart Failure
Acronym
SURE-HF
Condition
Worsening Heart Failure
Condition
Congestion
Condition
Heart Failure
Intervention (Drug)
Furosemide
Intervention (Device)
Horiba LAQUAtwin B-722
Lead sponsor
Nurgul Ablakimova (class: other)
Collaborator
I.M. Sechenov First Moscow State Medical University (class: other)

Record details

Record id
cardio:ct-nct07631780
Content hash
0ff945c0c59acc9a0d7ac594f3b4c752c28597d0c80ca555f54da86a0df920af